Cargando…
Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects
Pseudomyxoma peritonei (PMP, ORPHA26790) is a clinical syndrome characterized by progressive dissemination of mucinous tumors and mucinous ascites in the abdomen and pelvis. PMP is a rare disease with an estimated incidence of 1–2 out of a million. Clinically, PMP usually presents with a variety of...
Autores principales: | Amini, Afshin, Masoumi-Moghaddam, Samar, Ehteda, Anahid, Morris, David Lawson |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013295/ https://www.ncbi.nlm.nih.gov/pubmed/24886459 http://dx.doi.org/10.1186/1750-1172-9-71 |
Ejemplares similares
-
Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy
por: Amini, Afshin, et al.
Publicado: (2014) -
Depletion of mucin in mucin-producing human gastrointestinal carcinoma: Results from in vitro and in vivo studies with bromelain and N-acetylcysteine
por: Amini, Afshin, et al.
Publicado: (2015) -
Physical and chemical characteristics of mucin secreted by pseudomyxoma peritonei (PMP)
por: Pillai, Krishna, et al.
Publicado: (2017) -
Laparoscopic Mucin Removal in Patients with Pseudomyxoma Peritonei
por: Kotani, Yasushi, et al.
Publicado: (2009) -
The expression of the Sprouty 1 protein inversely correlates with growth, proliferation, migration and invasion of ovarian cancer cells
por: Masoumi-Moghaddam, Samar, et al.
Publicado: (2014)